Product logins

Find logins to all Clarivate products below.


Peripheral Vascular Devices | Market Insights | Japan | 2023

Growing adoption of premium-priced DES and DCBs will be fueled by the continued emergence of data supporting the safety of paclitaxel-coated devices, resulting in modest growth in the Japanese PV device market. The impact of the COVID-19 pandemic in the short term, as well as ASP declines caused by MHLW biennial reimbursement cuts over the forecast period, will limit market revenues.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for PV devices in Japan from 2019 through 2031.

Related Medtech Insights Reports

Report
Trauma Devices – Market Insights – Japan
The Japanese trauma device market will experience marginal growth through 2034, primarily fueled by the adoption of innovative, premium-priced technologies. This upward trend is further supported…
Report
Large-Joint Reconstructive Implants – Market Insights – Japan
Growth in large-joint reconstructive procedure volumes is being driven by favorable demographic trends and increased demand for innovative technologies. However, market expansion is partly…
Report
Cardiac Rhythm Management Devices – Market Insights – Japan
The Japanese CRM device market will grow over the forecast period. The introduction of novel products—such as the Aurora EV-ICD and dual-chamber leadless pacemakers—and favorable reimbursement…
Report
Neurovascular Devices – Market Insights – Japan
The Japanese neurovascular device market will experience moderate growth through 2034. This update reflects the impact of recent developments, including the launch of new-generation devices and…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Japan
The Japanese GI endoscopy device market is projected to experience modest expansion through 2034. This growth is driven by favorable treatment and screening guidelines, as well as an aging…